Recent Advances in Treating Schizophrenia

Access Activity

Overview / Abstract:

Target Audience

This activity is intended for physicians, physician assistants, nurse practitioners and registered nurses, pharmacists and psychologists engaged in the care of patients with schizophrenia.

Program Overview

Several novel and innovative therapies and therapeutic targets for schizophrenia are currently being investigated that are designed to target all, positive, or negative symptoms. This activity will focus on three main subject areas: unmet needs in the treatment of schizophrenia; innovative targets for drug discovery for schizophrenia; and current and emerging treatments for schizophrenia.The prevalence of insomnia changes throughout the lifespan, increasing after puberty, particularly in females, and continuing to increase throughout life. Although non-pharmacologic interventions are effective, patients often require pharmacologic interventions. In this program, we will discuss the latest developments in the treatment of insomnia in adolescent, adult geriatric, and dementia patients.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Discuss the unmet needs and treatment targets in schizophrenia
Describe evidence-based strategies for positive, negative and cognitive symptoms of schizophrenia
Apply innovative treatments for schizophrenia
Discuss new strategies to improve adherence and minimize side effects of antipsychotics

Expiration

Jan 20, 2022

Discipline(s)

Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE

Format

Online

Credits / Hours

1.0 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty

FACULTY_NAME
Jonathan Meyer, MD
Clinical Professor of Psychiatry
University of California, San Diego

Sponsors / Supporters / Grant Providers

Allergan, Eisai, Intra-Cellular Therapies, Jazz Pharmaceuticals, Neurocrine Biosciences, Sunovion, and Takeda.

Keywords / Search Terms

Relias LLC Relias LLC., FREE CME., Schizophrenia Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map